Perspectives: Drug Policies On Opioid Prescriptions Fall Short; Why Jack Up Costs Of Life-Saving Naloxone?
Opinion writers weigh in on health topics surrounding the opioid crisis.
Archives: Morning Breakouts
29,101 - 29,120 of 112,415 Results
-
-
Longer Looks: Caregivers In Prison; Medicare For All; Drunken Driving Laws
Each week, KHN's Shefali Luthra finds interesting reads from around the Web.
By khnshefalil -
State Highlights: Ohio City’s Last Abortion Clinic Reopens For Business; Sacramento Approves Hospice For Terminally Ill Homeless People
Media outlets report on news from Ohio, California, Massachusetts, Iowa, Missouri, New Hampshire, Mississippi, Illinois, Oregon and Florida.
By brilabuskes -
At Site For Proposed Border Wall Sits A Community That’s Burdened By Poor Health
"We're not just about the border wall or the river," says Rose Timmer, a community advocate. "We're about being fat, we're about being poor, we're about being illiterate." Such advocates are working to improve the health of those who straddle the country line.
By brilabuskes -
There’s Still Little Proof To Back Up Hype Over Combination Cancer Immunotherapies
All the buzz over combining experimental immune-boosting drugs with checkpoint inhibitors could fizzle into disappointment. In other public health news: eye treatments, aging athletes, the E. coli outbreak, hearing aids, and Ebola.
By brilabuskes -
Screening Rates For Lung Cancer ‘Truly Abysmal,’ Study Finds
The rates for other screenings are usually between 60 to 80 percent, while less than 2 percent of patients are taking advantage of lung screenings which can catch cancer while its still curable.
By brilabuskes -
Study Shows Breast Cancer Treatment Can Be Cut In Half: There’s No Longer A ‘Need To Throw The Kitchen Sink At It’
Typically, Herceptin is used for a year to treat breast cancer patients, but a new study finds it is effective with six months of use. The drug can damage the heart, and so a shorter amount of time taking it can improve patients' long-term health outcomes.
By brilabuskes -
San Francisco Launches Initiative To Seek Out Drug Users And Offer Anti-Addiction Prescriptions On The Street
Medication-assisted treatment with buprenorphine, methadone and naltrexone is widely considered the most effective way to wean users off opioids, but a major barrier is getting people the treatment. "We can’t wait for addicts to come to us. We have to go to them and engage. And offer. And give support,” said Barbara Garcia, director of health for the city and county of San Francisco.
By brilabuskes -
First Nonopioid Treatment To Ease Withdrawal Symptoms Approved By FDA
Regulators say that Lucemyra is not an addiction medicine but that it can be part of a longer-term treatment plan. "The physical symptoms of opioid withdrawal can be one of the biggest barriers for patients seeking help and ultimately overcoming addiction," says Dr. Scot Gottlieb, the FDA's commissioner.
By brilabuskes -
House Sends VA Choice Expansion Bill To Senate
The funding for the program that allows veterans to seek care outside the Veterans Affairs system is set to run out at the end of the month. Top Senate lawmakers say they hope to pass the legislation before that deadline.
By brilabuskes -
Vermont Legalizes Importation Of Drugs From Canada, But HHS Still Has To Approve Plan
The Trump administration has been vocal about its opposition to importing drugs from foreign countries as a way to lower costs, with HHS Secretary Alex Azar calling it a "gimmick."
By brilabuskes -
How Pharma Companies Build An Impenetrable Fortress Of Patents To Keep Generic Competition At Bay
"One of the barriers to competition that concerns me the most is when companies game the system by taking advantage of certain rules and laws," FDA Commissioner Scott Gottlieb has said. "They exploit loopholes in our system to delay generic entry. In these ways, they extend a drug's monopoly beyond what Congress intended." Meanwhile, despite any Medicare drug changes being a long shot, the pharmaceutical industry is worried.
By brilabuskes -
High Premiums A Political Hot Potato As Rates For Next Year Start To Come Out
Democrats are planning to be "relentless" in making sure Americans know who is responsible for the high costs, but Republicans say liberal lawmakers should look in the mirror. Meanwhile, a coalition of state attorneys general from blue states was granted the right to intervene in the lawsuit that seeks to dismantle the Affordable Care Act.
By brilabuskes -
Fertility Rate Hits Record Low In What Experts Call One Of ‘Biggest Demographic Mysteries Of Recent Times’
“Every year I look at data and expect it will be the year that birthrates start to tick up, and every year we hit another all-time low” in the United States, says Kenneth M. Johnson, a demographer at the University of New Hampshire.
By brilabuskes -
First Edition: May 17, 2018
Today's early morning highlights from the major news organizations.
By brilabuskes -
Viewpoints: After Corporations, Wealthy People Get A Boost, Brutality Takes Over Policies; Where’s The Research On Women’s Heart Disease?
Editorial writers look at these and other health topics.
By janicelkff -
Perspectives: Notion That Drug Costs In The United States Are Determined By Open Competition Is Fiction
Read recent commentaries about drug-cost issues.
By brilabuskes -
‘We’ve Gone From The Farm To The Pharm’: How The ‘Diabetes Belt’ Is Embracing This Insulin-Maker
News outlets report on stories related to pharmaceutical pricing.
By brilabuskes -
State Highlights: Chicago Teens Take On Gun Violence As Peace Warriors; Maryland Prohibits Gay Conversion Therapy For Minors
Media outlets report on news from Illinois, Maryland, Massachusetts, New Hampshire, California, Ohio, Pennsylvania, Minnesota, Texas, North Carolina,
By brilabuskes -
Judge Overturns Calif. Aid-In-Dying Law, Saying Legislature Illegally Passed Bill In Special Health Care Session
Plaintiffs argued that Gov. Jerry Brown called the special session to deal with a funding shortage for public health programs and the assisted death law did not meet that criteria. Superior Court Judge Daniel Ottolia is giving the state attorney general five days to appeal.
By brilabuskes